PAPAYA — all Canadian products
3 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PAPAYA, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02228033 | DIGESTION - CAP 300MG | LABORATOIRE LALCO INC. | Capsule | Oral | PAPAYA 300 MG | Cancelled Post Market | |
| 02051990 | FLORASUN PAPAYE CAP 300MG | LABORATOIRE LALCO INC. | Capsule | Oral | PAPAYA 300 MG | Cancelled Post Market | |
| 02193965 | FORMULA FOUR - WAF | HILLESTAD PHARMACEUTICALS USA | Wafer | Oral | PAPAYA 115 MG; ASPERGILLUS NIGER 35 MG; ASPERGILLUS ORYZAE 30 MG; PINEAPPLE 25 MG | Cancelled Post Market |
Browse other molecules: